BioCentury
ARTICLE | Clinical News

Atragen tretinoin: Phase I data; Phase II

May 21, 2001 7:00 AM UTC

In a 17-patient U.S. Phase I trial of Atragen in combination with interferon alpha, 2 of 16 evaluable patients who received 15 mg/m 2 dosages of Atragen showed partial remission in bone and lung metas...